{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T23:53:55Z","timestamp":1787961235772,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T00:00:00Z","timestamp":1707782400000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.pbb.2023.173525","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T21:12:13Z","timestamp":1675804333000},"page":"173525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The antidepressant agomelatine attenuates morphine-induced reinstatement but not self-administration or precipitated withdrawal"],"prefix":"10.1016","volume":"223","author":[{"given":"Alok","family":"De","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken W.","family":"Grasing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2023.173525_bb0005","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41386-019-0336-5","article-title":"Testing the 10 most wanted: a preclinical algorithm to screen candidate opioid use disorder medications","volume":"44","author":"Banks","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109296","article-title":"Veteran drug overdose mortality, 2010\u20132019","volume":"233","author":"Begley","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2023.173525_bb0015","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1139\/jpn.0414","article-title":"Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors","volume":"29","author":"Bourin","year":"2004","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.pbb.2023.173525_bb0020","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/add.14867","article-title":"Trends in opioid use disorder and overdose among opioid-naive individuals receiving an opioid prescription in Massachusetts from 2011 to 2014","volume":"115","author":"Burke","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2023.173525_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2017.12.023","article-title":"The behavioral pharmacology and therapeutic potential of lorcaserin for substance use disorders","volume":"142","author":"Collins","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0030","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1124\/jpet.115.228833","article-title":"Lorcaserin reduces the discriminative stimulus and reinforcing effects of cocaine in rhesus monkeys","volume":"356","author":"Collins","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2023.173525_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.03.001","article-title":"The role of human drug self-administration procedures in the development of medications","volume":"96","author":"Comer","year":"2008","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2023.173525_bb0040","series-title":"Guide for Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.pbb.2023.173525_bb0045","article-title":"Role of melatonin in the management of substance addiction: a systematic review","volume":"14","author":"Das","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.pbb.2023.173525_bb0050","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrd3140","article-title":"Agomelatine, the first melatonergic antidepressant: discovery, characterization and development","volume":"9","author":"de","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pbb.2023.173525_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-006-0529-6","article-title":"Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure","volume":"189","author":"Epstein","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0060","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuroscience.2016.02.019","article-title":"Effect of circadian rhythm disturbance on morphine preference and addiction in male rats: involvement of period genes and dopamine D1 receptor","volume":"322","author":"Garmabi","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2023.173525_bb0065","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3565(25)31261-9","article-title":"Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions","volume":"205","author":"Gellert","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2023.173525_bb0070","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/adb.12650","article-title":"The effects of melatonin supplementation on mental health, metabolic and genetic profiles in patients under methadone maintenance treatment","volume":"24","author":"Ghaderi","year":"2019","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pbb.2023.173525_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008877-200502000-00001","article-title":"Effects of high-dose selegiline on morphine reinforcement and precipitated withdrawal in dependent rats","volume":"16","author":"Grasing","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.phrs.2004.07.004","article-title":"Selegiline modifies the extinction of responding following morphine self-administration, but does not alter cue-induced reinstatement, reacquisition of morphine reinforcement, or precipitated withdrawal","volume":"51","author":"Grasing","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pbb.2023.173525_bb0085","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-003-1442-x","article-title":"A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats","volume":"168","author":"Grasing","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/FBP.0000000000000672","article-title":"Biphasic reward effects are characteristic of both lorcaserin and drugs of abuse: implications for treatment of substance use disorders","volume":"33","author":"Grasing","year":"2022","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0095","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/FBP.0000000000000472","article-title":"The muscarinic agonist pilocarpine modifies cocaine-reinforced and food-reinforced responding in rats: comparison with the cholinesterase inhibitor tacrine","volume":"30","author":"Grasing","year":"2019","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0100","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1111\/bph.12720","article-title":"Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties","volume":"171","author":"Guardiola-Lemaitre","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2008.07.049","article-title":"Melatonin reverses the expression of morphine-induced conditioned place preference through its receptors within central nervous system in mice","volume":"594","author":"Han","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00213-008-1079-x","article-title":"Controversies in translational research: drug self-administration","volume":"199","author":"Haney","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0115","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.pbb.2006.10.022","article-title":"L-methamphetamine and selective MAO inhibitors decrease morphine-reinforced and non-reinforced behavior in rats; insights towards selegiline's mechanism of action","volume":"85","author":"He","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173525_bb0120","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bja.2018.03.009","article-title":"Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis","volume":"120","author":"Higgins","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.pbb.2023.173525_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.666945","article-title":"Safety and preliminary efficacy of lorcaserin for cocaine use disorder: a phase I randomized clinical trial","volume":"12","author":"Johns","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pbb.2023.173525_bb0130","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/FBP.0b013e3283641c3d","article-title":"A review of human drug self-administration procedures","volume":"24","author":"Jones","year":"2013","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0135","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejphar.2018.09.025","article-title":"Lorcaserin decreases the reinforcing effects of heroin, but not food, in rhesus monkeys","volume":"840","author":"Kohut","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.pbb.2023.173525_bb0140","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neuropharm.2008.07.043","article-title":"Neurobiological substrates for the dark side of compulsivity in addiction","volume":"56","author":"Koob","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0145","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00008877-200312000-00006","article-title":"Differences in morphine and cocaine reinforcement under fixed and progressive ratio schedules; effects of extinction, reacquisition and schedule design","volume":"14","author":"Li","year":"2003","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drugalcdep.2016.05.022","article-title":"Development of a translational model to screen medications for cocaine use disorder II: choice between intravenous cocaine and money in humans","volume":"165","author":"Lile","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2023.173525_bb0155","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lfs.2016.03.032","article-title":"Melatonin reverses morphine tolerance by inhibiting microglia activation and HSP27 expression","volume":"152","author":"Lin","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2023.173525_bb0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013\u20132019","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.pbb.2023.173525_bb0165","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1038\/sj.npp.1301314","article-title":"Sex and menstrual cycle effects on progressive ratio measures of cocaine self-administration in cynomolgus monkeys","volume":"32","author":"Mello","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0170","first-page":"240","article-title":"Attenuation of morphine physical dependence and blood levels of cortisol by central and systemic administration of ramelteon in rat","volume":"40","author":"Motaghinejad","year":"2015","journal-title":"Iran. J. Med. Sci."},{"key":"10.1016\/j.pbb.2023.173525_bb0175","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/s41386-020-00815-4","article-title":"Learning from lorcaserin: lessons from the negative clinical trial of lorcaserin to treat cocaine use disorder","volume":"45","author":"Negus","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0180","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s00213-017-4726-2","article-title":"Choice between delayed food and immediate opioids in rats: treatment effects and individual differences","volume":"234","author":"Panlilio","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0185","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.pbb.2019.02.010","article-title":"The serotonin-2C agonist lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: a randomized, controlled human laboratory study","volume":"180","author":"Pirtle","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173525_bb0190","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0924-977X(00)00115-2","article-title":"Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation","volume":"10","author":"Raghavendra","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0195","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0006-8993(99)01520-6","article-title":"Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors","volume":"834","author":"Raghavendra","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2023.173525_bb0200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2999(00)00849-9","article-title":"Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice","volume":"409","author":"Raghavendra","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173525_bb0205","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neubiorev.2017.04.001","article-title":"Reconsidering depression as a risk factor for substance use disorder: insights from rodent models","volume":"77","author":"Rappeneau","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2023.173525_bb2000","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J","article-title":"Some comments on frequently used multiple endpoint adjustment methods in clinical trials","volume":"16","author":"Sankoh","year":"1997","journal-title":"Stat. Med."},{"key":"10.1016\/j.pbb.2023.173525_bb0210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002130050702","article-title":"Progressive-ratio schedules of drug delivery in the analysis of drug self-administration: a review","volume":"139","author":"Stafford","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0215","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/jeab.757","article-title":"Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience","volume":"117","author":"Strickland","year":"2022","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.pbb.2023.173525_bb0220","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00213-017-4576-y","article-title":"Melatonin reduces motivation for cocaine self-administration and prevents relapse-like behavior in rats","volume":"234","author":"Takahashi","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2023.173525_bb0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.nbd.2018.04.005","article-title":"Chronic agomelatine treatment prevents comorbid depression in the post-status epilepticus model of acquired epilepsy through suppression of inflammatory signaling","volume":"115","author":"Tchekalarova","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pbb.2023.173525_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2018.05.016","article-title":"Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light","volume":"171","author":"Tchekalarova","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173525_bb0235","first-page":"11","article-title":"Medications development for treatment of opioid use disorder","author":"Townsend","year":"2021","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.pbb.2023.173525_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107848","article-title":"Lorcaserin maintenance fails to attenuate heroin vs. food choice in rhesus monkeys","volume":"208","author":"Townsend","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2023.173525_bb0245","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1369-1600.2007.00070.x","article-title":"Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade","volume":"12","author":"Tzschentke","year":"2007","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pbb.2023.173525_bb0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/lm.050187.119","article-title":"Acute ovarian hormone treatment in freely cycling female rats regulates distinct aspects of heroin seeking","volume":"27","author":"Vazquez","year":"2020","journal-title":"Learn. Mem."},{"key":"10.1016\/j.pbb.2023.173525_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108484","article-title":"Causes of death among U.S. Veterans with a prior nonfatal opioid overdose","volume":"219","author":"Warfield","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2023.173525_bb0260","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/milmed\/usab485","article-title":"The public health approach to the worsening opioid crisis in the United States calls for harm reduction strategies to mitigate the harm from opioid addiction and overdose deaths","volume":"187","author":"Yeo","year":"2022","journal-title":"Mil. Med."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305723000126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305723000126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:44:19Z","timestamp":1758775459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305723000126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":53,"alternative-id":["S0091305723000126"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173525","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antidepressant agomelatine attenuates morphine-induced reinstatement but not self-administration or precipitated withdrawal","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"173525"}}